A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis

Journal of Aerosol Medicine and Pulmonary Drug Delivery, Ahead of Print.

Source: Journal of Aerosol Medicine and Pulmonary Drug Delivery - September 22, 2023 Category: Respiratory Medicine Authors: Hiroyuki Doi Jun Atsumi David Baratz Yohei Miyamoto Source Type: research